{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:08:38Z","timestamp":1769044118481,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diabetes poses a risk to diabetic keratopathy in up to two-thirds of patients. Insulin-degrading enzyme (IDE) is a protease that can break down insulin and several growth factors and may impair wound healing. Increased IDE levels have been found in fluid from diabetic skin ulcers. This study sought to determine the effect of IDE inhibitor on corneal wound healing in a rat model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Thirty-four male Wistar rats were divided into two groups: no diabetes and streptozocin-induced diabetes. Six weeks later, a 4-mm central corneal erosion was created under anesthesia in the right eye of all rats. In each group, half the rats were treated with ADT21 drops (IDE inhibitor) and half with NaCl 0.9% (sham) drops, four times daily. Image J analysis was performed to evaluate the area of erosion and healing rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There was a trend for more rapid healing in rats treated with IDEI than NaCl drops, regardless of the diabetic condition. Comparison of erosion closure over time revealed that the wounds closed significantly more quickly in the non-diabetic rats treated with IDEI than in the non-diabetic rats treated with NaCl (<jats:italic>p<\/jats:italic>\u2009=\u20090.045), overall mean closure time 56.00\u00a0h, 95% CI [50.54, 61.46]. No such difference was seen in the diabetic group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>To our knowledge, this is the first study to test ADT21 drops as a novel treatment for corneal wound repair. Our results suggest a potential benefit of IDE inhibitor for treating corneal injury.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00417-024-06717-1","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T07:37:24Z","timestamp":1734939444000},"page":"1015-1021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of insulin-degrading enzyme inhibitor for the treatment of corneal erosion in a rat model"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6817-9161","authenticated-orcid":false,"given":"Levy","family":"Issac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dollberg","family":"Dolev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Irit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dotan","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"6717_CR1","doi-asserted-by":"publisher","unstructured":"Papatheodorou K, Banach M, Bekiari E et al (2018) Complications of Diabetes 2017. J Diabetes Res :3086167. https:\/\/doi.org\/10.1155\/2018\/3086167","DOI":"10.1155\/2018\/3086167"},{"key":"6717_CR2","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1167\/iovs.11-7709","volume":"52","author":"J Yin","year":"2011","unstructured":"Yin J, Huang J, Chen C et al (2011) Corneal Complications in streptozocin-induced type I diabetic rats. Invest Ophthalmol Vis Sci 52:6589\u20136596. https:\/\/doi.org\/10.1167\/iovs.11-7709","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6717_CR3","doi-asserted-by":"publisher","unstructured":"Han SB, Yang HK, Hyon JY (2019) Influence of diabetes mellitus on anterior segment of the eye. Clin Interv Aging 53\u201363. https:\/\/doi.org\/10.2147\/CIA.S190713","DOI":"10.2147\/CIA.S190713"},{"key":"6717_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ajo.2019.09.010","volume":"209","author":"J Hafner","year":"2020","unstructured":"Hafner J, Zadrazil M, Grisold A et al (2020) Retinal and Corneal Neurodegeneration and Their Association with Systemic Signs of Peripheral Neuropathy in Type 2 Diabetes. Am J Ophthalmol 209:197\u2013205. https:\/\/doi.org\/10.1016\/j.ajo.2019.09.010","journal-title":"Am J Ophthalmol"},{"key":"6717_CR5","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.2337\/DC14-0860","volume":"37","author":"V Achtsidis","year":"2014","unstructured":"Achtsidis V, Eleftheriadou I, Kozanidou E et al (2014) Dry Eye Syndrome in Subjects With Diabetes and Association With Neuropathy. Diabetes Care 37:e210\u2013e211. https:\/\/doi.org\/10.2337\/DC14-0860","journal-title":"Diabetes Care"},{"key":"6717_CR6","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1038\/nutd.2017.4","volume":"7","author":"KC Shih","year":"2017","unstructured":"Shih KC, Lam KL, Tong L (2017) A systematic review on the impact of diabetes mellitus on the ocular surface. Nutr Diabetes 7:e251","journal-title":"Nutr Diabetes"},{"key":"6717_CR7","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1097\/OPX.0000000000000616","volume":"92","author":"H Ye","year":"2015","unstructured":"Ye H, Lu Y (2015) Corneal bullous epithelial detachment in diabetic cataract surgery. Optom Vis Sci 92:e161\u2013e164. https:\/\/doi.org\/10.1097\/OPX.0000000000000616","journal-title":"Optom Vis Sci"},{"key":"6717_CR8","first-page":"1","volume":"20","author":"IA Mirsky","year":"1949","unstructured":"Mirsky IA, Broh-Kahn RH (1949) The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts. Arch Biochem 20:1\u20139","journal-title":"Arch Biochem"},{"key":"6717_CR9","doi-asserted-by":"publisher","unstructured":"Mirsky IA, Perisutti G (1955) Effect of insulinase-inhibitor on hypoglycemic action of insulin. Science (1979) 122:559\u2013560. https:\/\/doi.org\/10.1126\/science.122.3169.559","DOI":"10.1126\/science.122.3169.559"},{"key":"6717_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/NATURE13297","volume":"511","author":"JP Maianti","year":"2014","unstructured":"Maianti JP, McFedries A, Foda ZH et al (2014) Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature 511:94\u201398. https:\/\/doi.org\/10.1038\/NATURE13297","journal-title":"Nature"},{"key":"6717_CR11","doi-asserted-by":"publisher","first-page":"e21374","DOI":"10.1096\/FJ.201901945R","volume":"35","author":"Y Nash","year":"2021","unstructured":"Nash Y, Ganoth A, Borenstein-Auerbach N et al (2021) From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment. FASEB J 35:e21374. https:\/\/doi.org\/10.1096\/FJ.201901945R","journal-title":"FASEB J"},{"key":"6717_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12020-020-02548-2","volume":"71","author":"Y Sofer","year":"2021","unstructured":"Sofer Y, Nash Y, Osher E et al (2021) Insulin-degrading enzyme higher in subjects with metabolic syndrome. Endocrine 71:357\u2013364. https:\/\/doi.org\/10.1007\/s12020-020-02548-2","journal-title":"Endocrine"},{"key":"6717_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1210\/jc.2003-031371","volume":"89","author":"WC Duckworth","year":"2004","unstructured":"Duckworth WC, Fawcett J, Reddy S, Page JC (2004) Insulin-Degrading Activity in Wound Fluid. J Clin Endocrinol Metab 89:847\u2013851. https:\/\/doi.org\/10.1210\/jc.2003-031371","journal-title":"J Clin Endocrinol Metab"},{"key":"6717_CR14","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1172\/JCI112243","volume":"73","author":"GR Grotendorst","year":"1985","unstructured":"Grotendorst GR, Martin GR, Pencev D et al (1985) Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 73:2323\u20132329. https:\/\/doi.org\/10.1172\/JCI112243","journal-title":"J Clin Invest"},{"key":"6717_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/archsurg.1990.01410190124021","volume":"125","author":"PJ Hennessey","year":"1990","unstructured":"Hennessey PJ, Black CT, Andrassy RJ (1990) Epidermal Growth Factor and Insulin Act Synergistically During Diabetic Healing. Arch Surg 125:926\u2013929. https:\/\/doi.org\/10.1001\/archsurg.1990.01410190124021","journal-title":"Arch Surg"},{"key":"6717_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/157339912800840479","volume":"8","author":"G Bikbova","year":"2012","unstructured":"Bikbova G, Oshitari T, Tawada A, Yamamoto S (2012) Corneal changes in diabetes mellitus. Curr Diabetes Rev 8:294\u2013302. https:\/\/doi.org\/10.2174\/157339912800840479","journal-title":"Curr Diabetes Rev"},{"key":"6717_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2337\/DB08-0997","volume":"58","author":"KP Xu","year":"2009","unstructured":"Xu KP, Li Y, Ljubimov AV, Yu FSX (2009) High glucose suppresses epidermal growth factor receptor\/phosphatidylinositol 3-kinase\/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes 58:1077\u20131085. https:\/\/doi.org\/10.2337\/DB08-0997","journal-title":"Diabetes"},{"key":"6717_CR18","first-page":"963","volume":"43","author":"EM Rocha","year":"2002","unstructured":"Rocha EM, Cunha DA, Carneiro EM, Boschero AC, Saad MJVLA (2002) Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular sur. Invest Ophthalmol Vis Sci 43:963\u2013967","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6717_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2337\/DIABETES.55.04.06.DB05-1581","volume":"55","author":"IS Zagon","year":"2006","unstructured":"Zagon IS, Sassani JW, McLaughlin PJ (2006) Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats. Diabetes 55:1141\u20131147. https:\/\/doi.org\/10.2337\/DIABETES.55.04.06.DB05-1581","journal-title":"Diabetes"},{"key":"6717_CR20","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.2337\/diabetes.51.10.3055","volume":"51","author":"IS Zagon","year":"2002","unstructured":"Zagon IS, Jenkins JB, Sassani JW et al (2002) Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. Diabetes 51:3055\u20133062. https:\/\/doi.org\/10.2337\/diabetes.51.10.3055","journal-title":"Diabetes"},{"key":"6717_CR21","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/ICO.0000000000001297","volume":"36","author":"AL Wang","year":"2017","unstructured":"Wang AL, Weinlander E, Metcalf BM et al (2017) Use of Topical Insulin to Treat Refractory Neurotrophic Corneal Ulcers. Cornea 36:1426\u20131428. https:\/\/doi.org\/10.1097\/ICO.0000000000001297","journal-title":"Cornea"},{"key":"6717_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/J.OFTAL.2018.06.003","volume":"94","author":"V Galvis","year":"2019","unstructured":"Galvis V, Ni\u00f1o CA, Tello A et al (2019) Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma. Arch Soc Esp Oftalmol 94:100\u2013104. https:\/\/doi.org\/10.1016\/J.OFTAL.2018.06.003","journal-title":"Arch Soc Esp Oftalmol"},{"key":"6717_CR23","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1177\/1120672120958307","volume":"31","author":"D Diaz-Valle","year":"2021","unstructured":"Diaz-Valle D, Burgos-Blasco B, Gegundez-Fernandez JA et al (2021) Topical insulin for refractory persistent corneal epithelial defects. Eur J Ophthalmol 31:2280\u20132286. https:\/\/doi.org\/10.1177\/1120672120958307","journal-title":"Eur J Ophthalmol"},{"key":"6717_CR24","doi-asserted-by":"publisher","first-page":"e912","DOI":"10.1111\/AOS.14997","volume":"100","author":"D Diaz-Valle","year":"2022","unstructured":"Diaz-Valle D, Burgos-Blasco B, Rego-Lorca D et al (2022) Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea. Acta Ophthalmol 100:e912\u2013e919. https:\/\/doi.org\/10.1111\/AOS.14997","journal-title":"Acta Ophthalmol"},{"key":"6717_CR25","doi-asserted-by":"publisher","unstructured":"Zhe TZ, To HY, Shih KC, Tong L (2023) New developments in the management of persistent corneal epithelial defects. Surv Ophthalmol S0039-6257https:\/\/doi.org\/10.1016\/j.survophthal.2023.06.001.","DOI":"10.1016\/j.survophthal.2023.06.001"},{"key":"6717_CR26","unstructured":"Vaidyanathan U, Hopping GC, Liu HY et al (2019) Persistent Corneal Epithelial Defects: A Review Article. Med Hypothesis Discov Innov Ophth 8:163\u2013176"},{"key":"6717_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF02913315","volume":"22","author":"A Akbarzadeh","year":"2007","unstructured":"Akbarzadeh A, Norouzian D, Mehrabi MR et al (2007) Induction of diabetes by Streptozotocin in rats. Indian J Clin Biochem 22:60\u201364. https:\/\/doi.org\/10.1007\/BF02913315","journal-title":"Indian J Clin Biochem"},{"key":"6717_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/J.BIOPHA.2017.08.098","volume":"95","author":"S Gheibi","year":"2017","unstructured":"Gheibi S, Kashfi K, Ghasemi A (2017) A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin. Biomed Pharmacother 95:605\u2013613. https:\/\/doi.org\/10.1016\/J.BIOPHA.2017.08.098","journal-title":"Biomed Pharmacother"},{"key":"6717_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/10520295.2017.1371333","volume":"92","author":"S Altan","year":"2017","unstructured":"Altan S, Sa\u011fs\u00f6z H, O\u011furtan Z (2017) Topical dimethyl sulfoxide inhibits corneal neovascularization and stimulates corneal repair in rabbits following acid burn. Biotech Histochem 92:619\u2013636. https:\/\/doi.org\/10.1080\/10520295.2017.1371333","journal-title":"Biotech Histochem"},{"key":"6717_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/J.DSX.2015.04.007","volume":"9","author":"S Noor","year":"2015","unstructured":"Noor S, Zubair M, Ahmad J (2015) Diabetic foot ulcer\u2013A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 9:192\u2013199. https:\/\/doi.org\/10.1016\/J.DSX.2015.04.007","journal-title":"Diabetes Metab Syndr"},{"key":"6717_CR31","doi-asserted-by":"publisher","unstructured":"Yang P, Wang X, Wang D et al (2020) Topical insulin application accelerates diabetic wound healing by promoting anti-inflammatory macrophage polarization. J Cell Sci 133. https:\/\/doi.org\/10.1242\/JCS.235838","DOI":"10.1242\/JCS.235838"},{"key":"6717_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0193101","volume":"13","author":"CN Suire","year":"2018","unstructured":"Suire CN, Nainar S, Fazio M et al (2018) Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display. PLoS ONE 13:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0193101","journal-title":"PLoS ONE"},{"key":"6717_CR33","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/cells11101621","volume":"11","author":"A S\u00e1nchez-Cruz","year":"2022","unstructured":"S\u00e1nchez-Cruz A, Hern\u00e1ndez-Fuentes MD, Murillo-G\u00f3mez C et al (2022) Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa. Cells 11:1621. https:\/\/doi.org\/10.3390\/cells11101621","journal-title":"Cells"},{"key":"6717_CR34","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/ARCHOPHT.125.8.1082","volume":"125","author":"IS Zagon","year":"2007","unstructured":"Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ (2007) Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. Arch Ophthalmol 125:1082\u20131088. https:\/\/doi.org\/10.1001\/ARCHOPHT.125.8.1082","journal-title":"Arch Ophthalmol"},{"key":"6717_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.BRAINRESBULL.2006.12.007","volume":"72","author":"IS Zagon","year":"2007","unstructured":"Zagon IS, Sassani JW, Myers RL, McLaughlin PJ (2007) Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium. Brain Res Bull 72:18\u201324. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2006.12.007","journal-title":"Brain Res Bull"}],"updated-by":[{"DOI":"10.1007\/s00417-025-06932-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000}}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06717-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06717-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06717-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T02:16:54Z","timestamp":1757125014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06717-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6717"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06717-1","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00417-025-06932-4","asserted-by":"object"}]},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00417-025-06932-4","URL":"https:\/\/doi.org\/10.1007\/s00417-025-06932-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This Research involving Animals. The experimental protocol was approved by our institutional Animal Care and Use Committee of Rabin Medical Center (approval #02720). Animals were housed in appropriate conditions, and procedures were designed to minimize pain, distress, and suffering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors confirm that they have no affiliations or involvement with any organisation or entity that has financial or non-financial interests in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}